Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHarvey Nash Group Regulatory News (HVN)

  • There is currently no data for HVN

Director/PDMR Shareholding

29 Oct 2018 07:00

RNS Number : 3880F
Harvey Nash Group PLC
29 October 2018
 

29 October 2018

 

Director/PDMR Shareholding

Harvey Nash Group Plc

("the Company")

Notification of Transaction by Directors

In accordance with DTR 3.1 and Article 19 of The Market Abuse Regulation, the Company was advised on 26 October 2018 that Albert Ellis, Simon Wassall and Mark Garratt had acquired ordinary shares in London on 26 October 2018 at a price of £0.05 per ordinary share as a result of the exercise of options granted under the Company's Performance Share Plan which became exercisable as a result of the offer by The Power of Talent Ltd being declared wholly unconditional on 26 October 2018:

Director

Number of shares purchased

Price per share

Resulting holding

Albert Ellis

1,385,499

£0.05

2,267,084*

Simon Wassall

930,215

£0.05

1,259,331

Mark Garratt

381,229

£0.05

416,787

*Includes 658,923 ordinary shares held by family members.

The notification below provides further detail.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them. 

1

Details of the person discharging managerial responsibility

a)

Name

Albert Ellis

2

Reason for the notification

a)

Position/status

Chief Executive

 

b)

Initial notification/amendment

Initial notification

 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Full name of the entity

Harvey Nash Group plc

b)

Legal Entity Identifier Code

2138004ULQUX3DQSCV07

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary shares of £0.05 each

ISIN: GB0006573546

c)

Nature of the transaction

Acquisition through Company Performance Share Plan.

e)

Price(s) and Volume(s)

Exercise:

Price(s) per share

Volume(s)

Aggregate Price

£0.05

1,385,499

£69,274.95

 

 

 

g)

Date of transaction

26 October 2018

h)

Place of transaction

London Stock Exchange XLON

 

1

Details of the person discharging managerial responsibility

a)

Name

Simon Wassall

2

Reason for the notification

a)

Position/status

European Managing Director

 

b)

Initial notification/amendment

Initial notification

 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Full name of the entity

Harvey Nash Group plc

b)

Legal Entity Identifier Code

2138004ULQUX3DQSCV07

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary shares of £0.05 each

ISIN: GB0006573546

c)

Nature of the transaction

Acquisition through Company Performance Share Plan.

e)

Price(s) and Volume(s)

Exercise:

Price(s) per share

Volume(s)

Aggregate Price

£0.05

930,215

£46,510.75

 

 

 

g)

Date of transaction

26 October 2018

h)

Place of transaction

London Stock Exchange XLON

 

1

Details of the person discharging managerial responsibility

a)

Name

Mark Garratt

2

Reason for the notification

a)

Position/status

Group Finance Director

 

b)

Initial notification/amendment

Initial notification

 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Full name of the entity

Harvey Nash Group plc

b)

Legal Entity Identifier Code

2138004ULQUX3DQSCV07

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary shares of £0.05 each

ISIN: GB0006573546

c)

Nature of the transaction

Acquisition through Company Performance Share Plan.

e)

Price(s) and Volume(s)

Exercise:

Price(s) per share

Volume(s)

Aggregate Price

£0.05

381,229

£19,061.45

 

 

 

g)

Date of transaction

26 October 2018

h)

Place of transaction

London Stock Exchange XLON

 

Contact:

Mark Garratt, Group Finance Director - 020 7333 0033

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHFEUFMMFASEES
Date   Source Headline
3rd Jun 20131:21 pmRNSHolding(s) in Company
31st May 20137:00 amRNSInterim Management Statement
31st May 20137:00 amRNSTotal Voting Rights
28th May 20135:27 pmRNSNotice of AGM
28th May 20131:02 pmRNSDirector/PDMR Shareholding
17th May 20136:08 pmRNSHolding(s) in Company
13th May 20134:15 pmRNSHolding(s) in Company
13th May 20132:55 pmRNSDirector/PDMR Shareholding
13th May 20132:55 pmRNSDirector/PDMR Shareholding
2nd May 20134:32 pmRNSDirector/PDMR Shareholding
1st May 20137:00 amRNSTotal Voting Rights
30th Apr 20134:29 pmRNSEBT Share Purchase
30th Apr 20137:02 amRNSDirectorate Appointment
30th Apr 20137:01 amRNSRegarding Acquisition
30th Apr 20137:00 amRNSHarvey Nash Joint Venture
30th Apr 20137:00 amRNSFinal Results
26th Apr 20135:44 pmRNSDirector/PDMR Shareholding
2nd Apr 20137:00 amRNSTotal Voting Rights
26th Mar 20133:32 pmRNSDirector/PDMR Shareholding
1st Mar 20137:00 amRNSTotal Voting Rights
28th Feb 20139:19 amRNSHolding(s) in Company
27th Feb 20135:08 pmRNSDirector/PDMR Shareholding
13th Feb 20137:00 amRNSPre-close trading update
31st Jan 20137:00 amRNSTotal Voting Rights
28th Jan 20134:42 pmRNSDirector/PDMR Shareholding
22nd Jan 20139:00 amRNSBusiness Leaders Tackle Gender Imbalance on Boards
8th Jan 20134:12 pmRNSHolding(s) in Company
8th Jan 201312:14 pmRNSHolding(s) in Company
31st Dec 20127:00 amRNSTotal Voting Rights
24th Dec 20128:21 amRNSDirector/PDMR Shareholding
14th Dec 20127:00 amRNSDirectorate Change
12th Dec 20127:00 amRNSBlocklisting Interim Review
30th Nov 20123:58 pmRNSDirector/PDMR Shareholding
30th Nov 20127:00 amRNSInterim Management Statement
30th Nov 20127:00 amRNSTotal Voting Rights
8th Nov 20121:11 pmRNSHolding(s) in Company
1st Nov 20127:00 amRNSTotal Voting Rights
30th Oct 20121:14 pmRNSDirector/PDMR Shareholding
29th Oct 20122:44 pmRNSDirector/PDMR Shareholding
18th Oct 20124:11 pmRNSEBT Share Purchase
17th Oct 20123:18 pmRNSDirector/PDMR Shareholding
1st Oct 20129:18 amRNSDirector/PDMR Shareholding
1st Oct 20127:00 amRNSTotal Voting Rights
28th Sep 20127:00 amRNSHalf Yearly Report
31st Aug 20124:48 pmRNSDirector/PDMR Shareholding
31st Aug 20127:00 amRNSTotal Voting Rights
13th Aug 20127:00 amRNSTrading Statement
1st Aug 20127:00 amRNSTotal Voting Rights
30th Jul 20124:50 pmRNSDirector/PDMR Shareholding
17th Jul 201212:28 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.